Be’er Sheva, Israel–based DiA’s AI-enabled 2D ultrasound applications have FDA clearance and a CE Mark. The applications are geared toward reducing variability and increasing the efficiency and accuracy of ultrasound analysis.
“Through our strategic partnership with DiA Imaging Analysis, we can deliver unprecedented diagnostic confidence and operational efficiency to point-of-care ultrasound imaging, as well as widen access to high quality and timely care both inside and outside of hospitals,” said Kees Wesdorp, chief business leader of Precision Diagnosis at Philips.
DiA Hila Goldman Aslan described Philips’ ultrasound devices as an “ideal platform for deploying AI-enabled solutions that will benefit patients by helping clinicians to make better-informed decisions.”
